Phase 1 Trial of Lonsurf with Irinotecan and Bevacizumab

NIAID Data Ecosystem2026-03-09 收录

下载链接：

https://www.omicsdi.org/dataset/ecrin-mdr-crc/2615622

下载链接

链接失效反馈

官方服务：

资源简介：

Interventions: 1 cycle is 28days. Lonsurf(25mg/m2)is administered orally twice daily in 1-5days and 8-12 days. Irinotecan(100mg/m2) and Bevacizumab(5mg/kg) is administered by injection in day 1 and day15. Primary outcome(s): Recommended dose:RD Study Design: single arm study, open(masking not used), uncontrolled control, single assignment, treatment purpose

创建时间：

2015-10-15